August 14, 2026 01:02 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Netaji row: Suvendu Adhikari govt strips BJP MP Anant Maharaj of state honour | Sukhbir Badal attacked by Nihang Sikh with kirpan at Maharashtra gurdwara; assailant detained | ‘If you cannot do it, we will pass an order’: Supreme Court’s final warning to Centre on food labels | ‘Time to move on’: Bombay HC sends strong message in Vijay Mallya-bank dispute | Netaji row explodes in Bengal: Suvendu Adhikari orders police action over ‘derogatory’ posts | Kolkata's NRS Hospital nurse found dead in washroom during night shift | RG Kar rape-murder case takes fresh turn as ex-TMC MLA Nirmal Ghosh arrested over cremation probe | ‘Govt has nothing to hide’: Amit Shah says ‘ready for debate’ on NEET crackdown; Rahul Gandhi hits back, ‘not interested in lecture’ | Tata Sons leadership shock: N Chandrasekaran won’t seek reappointment as chairman after February 2027 | ISI-linked Pakistani national arrested in Bengal over 'espionage' targeting Army, BSF, Railways
Adar Poonawalla
Image: Adar Poonawalla Instagram page

The news of rising COVID cases coming out of China is concerning: SII CEO Adar Poonawalla

| @indiablooms | Dec 21, 2022, at 08:42 pm

Mumbai: Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday expressed concern over the rising COVID-19 cases in China and said the issue is 'concerning'.

"The news of rising COVID cases coming out of China is concerning, we need not panic given our excellent vaccination coverage and track record," he tweeted.

He said people should continue following the guidelines issued by the Indian government to combat COVID-19.

"We must continue to trust and follow the guidelines set by the Government of India and @MoHFW_INDIA," he said.

Adar  Poonawalla is the CEO of  Serum Institute of India which manufactures Covishield COVID-19 vaccine.

China is witnessing a rise in COVID-19 cases in recent days.

Analysis by Airfinity shows between 1.3 and 2.1 million lives could be at risk if China lifts its zero-COVID policy given low vaccination and booster rates as well as a lack of hybrid immunity.

Airfinity’s risk analysis uses cumulative peak cases and deaths from Hong Kong's BA.1 wave as a proxy for mainland China.

Hong Kong took a zero-COVID approach for the first two years of the pandemic.

Therefore, when the more transmissible Omicron BA.1 sublineage hit back in February, population immunity from infection was low.

This, combined with a low vaccine coverage, led to a huge wave of both infections and deaths, especially amongst the elderly.

Mainland China has very low levels of immunity across its population.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.